Advanced glycation end productions and tendon stem/progenitor cells in pathogenesis of diabetic tendinopathy

doi:10.4252/wjsc.v13.i9.1338

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3534)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

297

WORD

122

HTML

2142

Figures (1-1)

145

Sum=2706

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

420

Download

408

Sum=828

Sep 26, 2021 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Sep 26, 2021; 13(9): 1338-1348
Published online Sep 26, 2021. doi: 10.4252/wjsc.v13.i9.1338

Open in New Tab Full Size Figure Download Figure

Figure 1 Hypothesis of the molecular mechanism by which advanced glycation end products regulate the fate of tendon-derived stem/progenitor cells in diabetic tendinopathy. RBCs: Red blood cells; AGEs: Advanced glycation end products; TSPCs: Tendon-derived stem/progenitor cells; RAGE: Receptor for advanced glycation end product; ROS: Reactive oxygen species; TGF-β: Transforming growth factor β.

Citation: Shi L, Lu PP, Dai GC, Li YJ, Rui YF. Advanced glycation end productions and tendon stem/progenitor cells in pathogenesis of diabetic tendinopathy. World J Stem Cells 2021; 13(9): 1338-1348
URL: https://www.wjgnet.com/1948-0210/full/v13/i9/1338.htm
DOI: https://dx.doi.org/10.4252/wjsc.v13.i9.1338